Nano-composite scaffolds for bone tissue engineering containing silver nanoparticles: preparation, characterization and biological properties
- 1.4k Downloads
In this study nano-composite scaffolds to be used as bone grafts have been endowed with antibacterial properties owing to the presence of silver nanoparticles. The alginate/hydroxyapatite composite scaffolds were prepared by internal gelation followed by a freeze-drying procedure to obtain a porous structure. The nanoparticles were prepared in presence of a lactose modified-chitosan and this colloidal solution was adsorbed on the scaffolds by exploiting electrostatic interactions. The adsorption and release of the silver from the composite scaffold was measured by ICP-AES and spectrofluorimetry measurements. Micro-computed tomography analysis of the scaffolds showed a homogeneous porous structure with average pore sizes of 341.5 μm and porosity of 80 %. In vitro biological tests (MTS and killing kinetics assays) demonstrated that silver does not affect the ability of the scaffolds to promote osteoblasts proliferation and that at the same time it exerts a strong bactericidal effect against both Gram+ and Gram− bacterial strains. Overall, the combined results indicate that these biocompatible antimicrobial scaffolds possess ideal characteristics for tissue engineering applications.
KeywordsChitosan Alginate Silver Nanoparticles Average Pore Size Composite Scaffold
This study was supported by the EU-FP6 Project “NEWBONE” (Contract Number 026279-2). The authors would like to thank Dott. Matteo Crosera for the ICP-AES analyses.
- 2.Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am. 1999;81(10):1434–45.Google Scholar
- 5.Stankovic A, Dimitrijevic S, Uskokovic D. Influence of size scale and morphology on antibacterial properties of ZnO powders hydrothemally synthesized using different surface stabilizing agents. Colloids Surf B. 2012;102C:21–8.Google Scholar
- 6.Wilkinson LJ, White RJ, Chipman JK. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. J Wound Care. 2011;20(11):543–9.Google Scholar
- 10.Travan A, Marsich E, Donati I, Paoletti S. Silver nanocomposites and their biomedical applications. In: Kumar C, editor. nanocomposites. Wiley: New York; 2010. p. 81–137.Google Scholar
- 12.Oei JD, Zhao WW, Chu L, Desilva MN, Ghimire A, Rawls HR, et al. Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B. 2011 [Epub ahead of print].Google Scholar
- 15.Tyllianakis M, Dalas E, Christofidou M, Kallitsis JK, Chrissanthopoulos A, Koutsoukos PG, et al. Novel composites materials from functionalized polymers and silver coated titanium oxide capable for calcium phosphate induction, control of orthopedic biofilm infections: an “in vitro” study. J Mater Sci Mater Med. 2010;21(7):2201–11.CrossRefGoogle Scholar
- 16.Das K, Bose S, Bandyopadhyay A, Karandikar B, Gibbins BL. Surface coatings for improvement of bone cell materials and antimicrobial activities of Ti implants. J Biomed Mater Res B. 2008;87(2):455–60.Google Scholar
- 17.Saravanan S, Nethala S, Pattnaik S, Tripathi A, Moorthi A, Selvamurugan N. Preparation, characterization and antimicrobial activity of a bio-composite scaffold containing chitosan/nano-hydroxyapatite/nano-silver for bone tissue engineering. Int J Biol Macromol. 2011;49(2):188–93.CrossRefGoogle Scholar
- 22.Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983;72(4):1396–409.CrossRefGoogle Scholar
- 23.Wake MC, Patrick CW Jr, Mikos AG. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant. 1994;3(4):339–43.Google Scholar
- 30.Koort JK, Makinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004;45(8):1406–11.Google Scholar